U.S. market Open. Closes in 1 hour 50 minutes

TVTX | Travere Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-11-302012-02-292011-02-28
Revenue145.24M212.02M227.49M198.32M175.34M164.25M154.94M133.59M99.89M28.20MN/AN/AN/AN/A
Cost of Revenue56.38M7.59M6.78M6.13M5.23M5.53M3.60M4.55M2.19M570.98KN/AN/AN/AN/A
Gross Profit88.86M204.43M220.71M192.19M170.10M158.72M151.33M129.04M97.71M27.63MN/AN/AN/AN/A
Operating Expenses465.60M455.99M360.21M267.57M269.91M227.41M182.13M168.87M129.97M107.44M23.97M30.26M12.82K12.69K
Selling, General & Admin227.87M220.21M149.88M135.80M128.95M103.65M103.96M98.02M79.54M59.64M16.89M30.26M12.82K12.69K
Research & Development237.73M235.78M210.33M131.77M140.96M123.76M78.17M70.85M50.43M47.80M7.08MN/AN/AN/A
Other Operating Expenses1.59M974.00K231.00K1.42M-314.00K-474.00KN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-376.74M-251.56M-139.50M-75.38M-99.81M-80.04M-53.79M-39.83M-32.26M-79.81M-23.97M-30.26M-12.82K-12.69K
Other Expenses / Income634.00K-26.61M-40.18M-113.41M-46.64M-28.86M-4.57M-17.75M137.73M-33.59M-9.78M-86.84K-2.00K-10.33K
Before Tax Income-376.11M-278.17M-179.68M-188.79M-146.45M-101.87M-58.36M-57.58M105.47M-113.40M-33.75M-30.34M-14.82K-23.02K
Income Tax Expenses223.00K313.00K409.00K-19.36M-21.00K811.00K1.37M-9.68M-11.77M-2.46M75.78KN/AN/AN/A
Net Income-111.40M-278.48M-180.09M-169.43M-146.43M-102.68M-59.73M-47.90M117.24M-110.94M-33.82M-30.34M-14.82K-23.02K
Interest Expenses11.33M11.28M20.14M19.05M18.83M9.81M1.19MN/A7.75MN/AN/A105.92K2.00K10.33K
Basic Shares Outstanding74.27M63.76M59.83M47.54M42.34M40.43M38.77M37.00M33.56M25.06M14.21M3.66M106.68K106.68K
Diluted Shares Outstanding74.27M63.76M59.83M47.54M42.34M40.43M38.77M38.29M37.58M25.06M14.21M3.66M106.68K106.68K
EBITDA-331.81M-244.31M-137.28M-68.95M-69.66M-63.67M-39.37M-41.45M126.61M-108.00M-14.03M-30.11M-12.82K-12.69K
EBITDA Margin-228.46%-115.23%-60.35%-34.77%-39.73%-38.76%-25.41%-31.03%126.74%-382.92%0.00%0.00%0.00%0.00%
EBIT-99.84M-266.89M-159.54M-169.74M-127.62M-92.06M-57.17M-57.58M113.22M-113.40M-33.75M-30.24M-12.82K-12.69K
EBIT Margin-68.74%-125.88%-70.13%-85.59%-72.79%-56.05%-36.90%-43.10%113.34%-402.07%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-11-302012-02-292011-02-28
An error has occurred. This application may no longer respond until reloaded. Reload 🗙